General Statement of Disclosure: OWNERSHIP/PARTNERSHIP/PRINCIPAL: opus medical(NONE), BioStar Ventures(NONE), global genomics group(NONE), HeartBeam(NONE) OTHER FINANCIAL BENEFIT: CVRx(NONE) View Full Disclosure